Literature DB >> 3002275

Immunochemical study on the mannans of Candida albicans NIH A-207, NIH B-792, and J-1012 strains prepared by fractional precipitation with cetyltrimethylammonium bromide.

N Shibata, T Ichikawa, M Tojo, M Takahashi, N Ito, Y Okubo, S Suzuki.   

Abstract

The mannans of Candida albicans NIH A-207 (A strain, serotype A), C. albicans NIH B-792 (B strain, serotype B), and C. albicans J-1012 (J strain, serotype C) prepared by fractional precipitation with cetyltrimethylammonium bromide (Cetavlon) were investigated for their immunochemical properties. Upon treatment with 10 mM HCl at 100 degrees C for 60 min, the mannans of A and B strains each released a mixture of manno-oligosaccharides ranging from hexaose to mannose together with (for each one) an acid-modified mannan, while J-strain mannan released lower oligosaccharides, tetraose to mannose. The acid-modified mannan of B strain did not show antibody-precipitating activity against homologous antiserum, whereas acid-modified A- and J-strain mannans retained most of this activity. The acid-released oligosaccharides were assumed to consist of beta-1,2-linked D-mannopyranosyl residues from the results of specific rotation and proton magnetic resonance studies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3002275     DOI: 10.1016/0003-9861(85)90511-9

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  33 in total

1.  Engineering of Yeast Glycoprotein Expression.

Authors:  Charlot De Wachter; Linde Van Landuyt; Nico Callewaert
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

2.  Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies.

Authors:  Y Han; T Kanbe; R Cherniak; J E Cutler
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

3.  Mannan composition of the hyphal form of two relatively avirulent mutants of Candida albicans.

Authors:  A Saxena; G E McElhaney-Feser; R L Cihlar
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

4.  Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate.

Authors:  Wen-Hsiang Chen; Lanying Du; Shivali M Chag; Cuiqing Ma; Nancy Tricoche; Xinrong Tao; Christopher A Seid; Elissa M Hudspeth; Sara Lustigman; Chien-Te K Tseng; Maria Elena Bottazzi; Peter J Hotez; Bin Zhan; Shibo Jiang
Journal:  Hum Vaccin Immunother       Date:  2013-12-30       Impact factor: 3.452

5.  Immunoreactivity of neoglycolipids constructed from oligomannosidic residues of the Candida albicans cell wall.

Authors:  C Faille; J C Michalski; G Strecker; D W Mackenzie; D Camus; D Poulain
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

6.  The Cek1‑mediated MAP kinase pathway regulates exposure of α‑1,2 and β‑1,2‑mannosides in the cell wall of Candida albicans modulating immune recognition.

Authors:  E Román; I Correia; A Salazin; C Fradin; T Jouault; D Poulain; F-T Liu; J Pla
Journal:  Virulence       Date:  2016-05-18       Impact factor: 5.882

7.  Isolation and preliminary characterization of the 14- to 18-kilodalton Candida albicans antigen as a phospholipomannan containing beta-1,2-linked oligomannosides.

Authors:  P A Trinel; M Borg-von-Zepelin; G Lepage; T Jouault; D Mackenzie; D Poulain
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Structural identification of an epitope of antigenic factor 5 in mannans of Candida albicans NIH B-792 (serotype B) and J-1012 (serotype A) as beta-1,2-linked oligomannosyl residues.

Authors:  N Shibata; M Arai; E Haga; T Kikuchi; M Najima; T Satoh; H Kobayashi; S Suzuki
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

9.  Presence of human antibodies reacting with Candida albicans O-linked oligomannosides revealed by using an enzyme-linked immunosorbent assay and neoglycolipids.

Authors:  M P Hayette; G Strecker; C Faille; D Dive; D Camus; D W Mackenzie; D Poulain
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

10.  Structures of cell wall mannans of pathogenic Candida tropicalis IFO 0199 and IFO 1647 yeast strains.

Authors:  H Kobayashi; K Matsuda; T Ikeda; M Suzuki; S Takahashi; A Suzuki; N Shibata; S Suzuki
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.